{"url_path":"/sec/idac/8-k/2026-05-18/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/2090441/0001213900-26-058549-index.html","accession_number":"0001213900-26-058549","cik":"0002090441","ticker":"IDAC","issuer_name":"Iron Dome Acquisition I Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2090441/0001213900-26-058549-index.html","primary_entity_key":"0002090441","primary_entity_name":"Iron Dome Acquisition I Corp."},"word_count":245,"has_tables":true,"body_markdown":"**Item 5.02 Departure of Directors or Certain Officers; Election of\nDirectors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n** **\n\nOn May 14, 2026, in\nconnection with the IPO, Eyal Waldman, David DeWalt and Paul Hodermarsky (the “New Directors” and, collectively with\nTom Y. Livne and Matthew J. Norden, the “Directors”) were appointed to the board of directors of the Company\n(the “Board”). Effective May 14, 2026, each of Eyal Waldman, David DeWalt and Paul Hodermarsky was also appointed to\nthe Board’s Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee, with David DeWalt serving\nas chair of the Audit Committee, Eyal Waldman  serving as the chair of the Compensation Committee, and Paul Hodermarsky serving as\nthe chair of the Nominating and Corporate Governance Committee.\n\n \n\nOn May 14, 2026, the Company\nentered into indemnity agreements with each of the Directors and officers of the Company, pursuant to which the Company has agreed to\nindemnify each officer and Director of the Company against certain claims that may arise in their roles as officers and directors of the\nCompany. The foregoing summary of the indemnity agreements does not purport to be complete and is subject to, and qualified in its entirety\nby, the full text of the indemnity agreements, a form of which is attached as Exhibit 10.6 hereto and incorporated in this Item 5.02 by\nreference. The Company will reimburse the Directors for reasonable out-of-pocket expenses incurred in connection with fulfilling their\nroles as directors."}